JDOC ETF Holdings

Holdings

Symbol	Grade	Price % Change	Allocation
LLY	F	-0.90	8.80
UNH	B	-0.52	8.71
TMO	D	0.39	4.58
ABBV	F	2.52	4.17
DHR	D	0.46	3.86
BSX	A	1.63	3.46
REGN	F	0.36	3.18
MCK	A	0.91	2.94
SYK	A	1.04	2.77
BMY	B	0.48	2.76
VRTX	D	-0.35	2.69
MDT	D	0.57	2.54
CI	D	1.94	2.46
JNJ	D	1.72	2.36
ISRG	A	1.67	1.65
HCA	F	-0.56	1.62
MRK	F	2.58	1.60
IQV	F	1.32	1.19
WST	C	2.48	1.00
EXAS	D	1.59	0.90
NTRA	A	1.12	0.85
CNC	F	1.82	0.83
DXCM	C	-0.57	0.81
AGIO	C	2.03	0.79
HALO	F	-0.72	0.78
ITCI	B	-0.18	0.77
NBIX	C	1.39	0.76
AMGN	D	0.57	0.71
INSP	F	0.73	0.69
HUM	C	0.75	0.69
BPMC	C	2.30	0.60
SRPT	F	-0.88	0.59
RVMD	B	-0.28	0.56
NVS	D	0.49	0.55
BMRN	F	1.52	0.55
TWST	F	2.32	0.52
BIIB	F	1.54	0.46
IRTC	C	0.45	0.42
ACHC	F	-1.76	0.41
ALNY	D	-0.68	0.38
APLS	F	1.09	0.33
ARVN	F	9.74	0.28
EVH	F	2.48	0.26
IDXX	F	-0.11	0.20

Represented by ETF Holdings

Keywords: S&P 500 Medicine Biopharmaceutical Biotechnology Life Sciences Nasdaq 100 Cancer Diabetes Clinical Medicine Infectious Diseases Mental Health Pharmaceutical Products Antibiotics Autoimmune Disease Bone Clinical Development Depressive Disorder Dow Jones Component Lab Testing Medicaid

Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Health Care Plans Medical Devices Medical Instruments & Supplies Medical Care Health Information Services Medical Distribution

Recent News for JPMorgan Healthcare Leaders ETF & its Holdings

Date	Stock	Title
Nov 21	LLY	Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
Nov 21	AMGN	Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
Nov 21	MRK	Merck & Co., Inc. (MRK) Jefferies London Healthcare Conference
Nov 21	APLS	Apellis started at equal-weight at Morgan Stanley on geographic atrophy market
Nov 21	BMY	Major companies that are also popular short-selling stocks
Nov 21	NVS	Novartis Elevates Midterm Sales Forecast, CEO Highlights Robust Pipeline
Nov 21	NVS	Novartis buys gene therapy developer Kate for up to $1.1B
Nov 21	MDT	Here's Why Medtronic (MDT) is a Strong Value Stock
Nov 21	DXCM	3 US Stocks Estimated To Be Trading At Discounts Of Up To 39.3%
Nov 21	MCK	McKesson Corporation (NYSE:MCK) is favoured by institutional owners who hold 89% of the company
Nov 21	CNC	Meridian Health Plan of Illinois and Liberty Bank and Trust Partner to Create Small Business Loan Program to Support and Empower Diverse and Small Businesses in Illinois
Nov 21	BMY	Is Bristol Myers Squibb Stock a Buy?
Nov 21	IDXX	IDEXX Laboratories CFO Brian McKeon to step down
Nov 21	IDXX	IDEXX Announces CFO Transition
Nov 21	NVS	Novartis raises mid-term sales guidance
Nov 21	MDT	3 Dividend Stocks I'll Never Sell
Nov 21	NVS	Novartis Lifts Midterm Sales Guidance Amid U.S. Expansion
Nov 21	NVS	Novartis wagers more than $1B on gene therapies for the nervous system
Nov 21	MRK	Merck Data at the ASH 2024 Annual Meeting Highlights Promising Hematology Pipeline With Diverse Range of Investigational Assets and Novel Modalities
Nov 21	AMGN	Analysis-Wall Street awaits Amgen weight-loss drug data expected to move shares

The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market. Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.
Biotechnology Venture Capital Medical Technology Healthcare Service Healthcare Technology

ETF Components for JDOC - JPMorgan Healthcare Leaders ETF